The hottest Regulatory Affairs Substack posts right now

And their main takeaways
Category
Top Business Topics

1DaySooner's Trump II Health Policy Proposals

Astral Codex Ten • 14935 implied HN points • 07 Feb 25
🏥 Health Politics Regulatory Affairs
  1. To improve kidney donations, policies may allow compensation for organ donors, which could help reduce the waiting list and save lives.
  2. There is a push for better transparency in healthcare data from the FDA, which could improve research and lead to safer medical products.
  3. Novel research ideas are often underfunded, so increasing support for unconventional studies and human challenge trials could speed up medical advancements.

FTC: Big Insurance’s PBMs “Profit at the Expense of Patients by Inflating Drug Costs and Squeezing Main Street Pharmacies"

HEALTH CARE un-covered • 579 implied HN points • 09 Jul 24
🇺🇸 U.S. Politics Regulatory Affairs
  1. Big insurance companies and pharmacy benefit managers (PBMs) are making money by increasing drug prices and hurting small pharmacies. This means patients often pay more for their medications.
  2. The FTC found that just six companies control most of the pharmacy benefit market, limiting options for patients and squeezing independent pharmacies.
  3. Many people struggle to afford their medications, with some saying they skip doses because of high costs. This shows the serious impact of PBMs on healthcare access.

Company behind Joe Namath Medicare Advantage ads has long rap sheet of misconduct

HEALTH CARE un-covered • 599 implied HN points • 20 Feb 24
🏥 Health Politics Regulatory Affairs
  1. The company behind Joe Namath's Medicare Advantage ads has a history of legal troubles and misconduct. This includes past penalties from federal agencies and a recent bankruptcy that some say was a way to avoid paying off legal liabilities.
  2. Over 31 million seniors are enrolled in Medicare Advantage plans, which can limit their access to doctors and hospitals. Many don't realize that signing up might mean losing their preferred healthcare providers, despite potential perks like gym memberships.
  3. Private equity firms play a big role in the Medicare Advantage market. They invest heavily in companies that often prioritize profits over genuine patient care, which can lead to misleading advertising and poor service for seniors.

UnitedHealth Group takes Wall Street hit because of investors' fears about Medicare Advantage profitability, Department of Justice antitrust investigation

HEALTH CARE un-covered • 519 implied HN points • 28 Feb 24
🏥 Health Politics Regulatory Affairs
  1. UnitedHealth Group is experiencing a big drop in its stock value because investors are worried about how profitable Medicare Advantage plans are. Many insurance companies are losing millions as healthcare usage by seniors increases.
  2. The Department of Justice is investigating UnitedHealth for possible antitrust issues related to its many acquisitions. This investigation is looking into how its insurance and healthcare services may be violating federal rules.
  3. There are growing concerns among both political parties about how Medicare Advantage plans are run. Bills are being introduced to make these plans more transparent and to reduce overpayments to them.

A win of sorts on something really important

The Crucial Years • 1743 implied HN points • 03 Dec 24
🌞 Climate & Environment Regulatory Affairs
  1. The Biden administration paused permits for new LNG export terminals, which could help reduce environmental damage. This decision is significant because increased LNG exports would greatly impact climate change.
  2. The Federal Energy Regulatory Commission (FERC) is now requiring more environmental reviews for these projects, which is a positive step for local communities affected by pollution. This could slow down the construction of new terminals, giving more time for analysis and opposition.
  3. There is growing evidence that exporting natural gas is just as harmful to the climate as exporting coal. People should understand the environmental and economic risks of increasing LNG exports, as it could lead to higher energy prices for American consumers.
Get a weekly roundup of the best Substack posts, by hacker news affinity:

Miracles In The (In)famous Pfizer Trial

QTR’s Fringe Finance • 25 implied HN points • 02 Feb 26
🏥 Health Politics Regulatory Affairs
  1. Reported vaccine effectiveness jumped sharply within about five to seven days after the second dose, which seems biologically implausible and makes that rapid change suspicious.
  2. The trial protocol let investigators treat symptoms in the first week after vaccination as side effects without PCR testing, so many potential COVID cases in the vaccine arm could have been missed and efficacy overstated.
  3. Vaccine recipients reported fewer non-COVID symptoms outside the immediate reactogenicity window, suggesting differential outcome ascertainment and bias that reduce confidence in the trial’s results.

US Dietary Guidelines Remain an Evidence-Free Zone

Unsettled Science • 1255 implied HN points • 11 Dec 24
🏥 Health Politics Regulatory Affairs
  1. Many clinical trials show that the recommended dietary changes may not actually improve health. In fact, some guidelines might worsen our health.
  2. The expert committee ignored strong evidence for reducing ultra-processed foods while pushing for less evidence-based recommendations on meat and dairy.
  3. Conflicts of interest within the expert committee raise questions about the validity of the guidelines, suggesting that politics may influence dietary recommendations over solid science.

It’s Time to Clear the Air on Juul

Common Sense with Bari Weiss • 217 implied HN points • 23 Jul 25
🏥 Health Politics Regulatory Affairs
  1. The FDA has authorized Juul's e-cigarettes for marketing after a long delay, and this decision has caused surprisingly little backlash.
  2. The once widespread concern about youth vaping has decreased significantly, with much fewer high school students using Juul compared to previous years.
  3. The debate around Juul seems to have shifted, as many health organizations have not raised strong objections following the FDA's recent decision.

Universal Repeated mRNA Boosting Was (and is) Bad Policy

Who is Robert Malone • 12 implied HN points • 03 Feb 26
🏥 Health Politics Regulatory Affairs
  1. Repeated, frequent mRNA boosters push the immune system toward a tolerance-style response (higher IL-10 and IgG4), so antibodies still bind the virus but trigger less inflammation and cell-killing—this helps prevent severe illness but does not reliably stop infection or spread.
  2. A one-size-fits-all policy of universal, frequent boosting was adopted without solid prospective evidence or proper timing studies, producing predictable immune 'signal stacking'; booster strategies should be risk-stratified, experimentally timed, and driven by shared decision-making.
  3. The tolerance-leaning immune shift from repeated boosting could affect responses to other vaccines and infections and might impair anti-tumor immune surveillance in some contexts, so booster spacing and long-term consequences warrant careful study.

Alter.systems AI is Refreshingly Different

Who is Robert Malone • 21 implied HN points • 28 Dec 25
🏥 Health Politics Regulatory Affairs
  1. Robert Malone is described as an early pioneer of mRNA vaccine technology who later became a vocal critic of how those vaccines were developed and deployed.
  2. His public warnings led to censorship and controversy, but he embraced the role of a dissenter, grew a large independent following, and gained positions like a CDC vaccine panel seat and an adjunct professorship.
  3. The piece praises Alter.systems as a new chat AI that claims to avoid institutional bias and censorship, recommending it as a freer alternative to mainstream models.

A Revolution in Vaccine Regulation and Approval

Who is Robert Malone • 35 implied HN points • 29 Nov 25
🏥 Health Politics Regulatory Affairs
  1. The FDA has found that at least 10 children died after receiving the COVID-19 vaccine, which raises serious safety concerns. This suggests that vaccine mandates may have caused more harm than good for young children.
  2. There is little reliable data showing that COVID-19 vaccines save lives in children, and the risks of vaccination may outweigh the benefits for this age group. The current situation calls for a reevaluation of vaccine approval processes and safety measures.
  3. The overall approach to vaccine regulation needs to change to prioritize evidence-based medicine. This includes better studies on vaccine safety and effectiveness, especially for young people, and being honest about the potential dangers of vaccines.

Big Pharma Millions Behind Attacks On Trump’s FDA Nominee

Public • 419 implied HN points • 24 Nov 24
🇺🇸 U.S. Politics Regulatory Affairs
  1. Dr. Marty Makary has been nominated by Trump to be the commissioner of the FDA. He has some controversial views that have stirred up discussions among experts.
  2. There are claims that attacks on Makary's nomination are backed by the pharmaceutical industry. This situation raises questions about conflicting interests in health policy.
  3. Makary defends other controversial figures, suggesting they have evolved in their views. However, this has led to further criticism from leading health experts.

What does the EU really want from Meta?

Tech + Regulation • 39 implied HN points • 28 May 24
🇺🇸 U.S. Politics Regulatory Affairs
  1. The EU is investigating Meta to ensure it protects children online, focusing on how well age verification tools work. They are concerned that many kids lies about their age, making current methods ineffective.
  2. Meta has implemented various methods for age assurance, including AI and human checks, but there are still challenges in verifying minors' ages accurately. They often use self-reported ages, which aren't reliable.
  3. The introduction of digital IDs is being discussed as a possible solution for age verification. However, there are concerns about how these IDs will be used and if they truly solve the problem of verifying minors' ages.

Roots, Origins and Lies

Who is Robert Malone • 15 implied HN points • 16 Dec 25
🏥 Health Politics Regulatory Affairs
  1. A sudden novel coronavirus outbreak upended a quiet life and pushed experienced scientists and clinicians into intense, urgent work to model the virus, repurpose drugs, and help communities prepare.
  2. Public health agencies, big tech platforms, and mainstream media coordinated information controls that led to censorship and suppression of dissenting medical views.
  3. There is a strong call for transparency, open scientific scrutiny, protection for whistleblowers, and defense of free speech and democratic checks to prevent institutional overreach during health emergencies.

Covid shots don't need to be 'pulled' from the market, we just need to stop giving EUA to boosters without data

Vinay Prasad's Observations and Thoughts • 199 implied HN points • 31 Dec 24
🏥 Health Politics Regulatory Affairs
  1. Most people who want COVID shots are getting them, while those who don't want them simply aren't taking them. There's no need to remove the vaccines from the market.
  2. The FDA should require proper clinical trials for COVID boosters to gather real data on their effectiveness. This would help clarify the true benefits and risks of the vaccines.
  3. Calling for all COVID shots to be pulled from the market is unhelpful and distracts from the need for transparency and accuracy in vaccine data. Better studies will provide clearer answers.

AI Oligarchs: Money Before Country, Again

God's Spies by Thomas Neuburger • 115 implied HN points • 28 Jan 25
🇺🇸 U.S. Politics Regulatory Affairs
  1. U.S. industrial policy has focused on moving jobs overseas to benefit the wealthy, which has hurt the country's economy. Instead of helping the average person, it seems to make the rich even richer.
  2. The tech industry in the U.S. has missed out on competition and innovation because companies put profit before progress. This has allowed cheaper and better technologies from other countries, like China, to take over.
  3. Lina Khan, a regulatory leader, warned that lack of competition in the tech industry would hurt U.S. companies in the long run. It looks like her concerns have come true as American firms are now struggling against more agile competitors.

MenQuadfi Approval and the Pyramid Scheme of Vaccine Safety

Injecting Freedom • 46 implied HN points • 15 Jun 25
🏥 Health Politics Regulatory Affairs
  1. The FDA approved the MenQuadfi vaccine for infants based on a study that compared it to another vaccine, Menveo, even though both showed serious side effects.
  2. There's a chain reaction of approvals where previous vaccines are used as controls without proper safety testing, creating a cycle that's hard to break.
  3. The safety standards for these vaccines are questionable, as the FDA relies on the very companies selling the vaccines to explain away any serious problems.

More suggestions for FDA reform for a Trump presidency

Vinay Prasad's Observations and Thoughts • 98 implied HN points • 07 Nov 24
🏥 Health Politics Regulatory Affairs
  1. The FDA should stop allowing pharmaceutical companies to advertise directly to consumers. This could help reduce biased promotion of drugs.
  2. It's important to improve transparency in the FDA's decision-making process and ensure that medical advice is based on solid evidence.
  3. We need better oversight of the fees the FDA charges for reviews so that smaller businesses aren't unfairly priced out, and more funding should go into tracking the safety of drugs after they are approved.

Why is Dr. Scott Gottlieb so desperate to keep Robert F. Kennedy Jr. out of Trump's cabinet?

Unreported Truths • 67 implied HN points • 02 Dec 24
🇺🇸 U.S. Politics Regulatory Affairs
  1. Dr. Scott Gottlieb is openly opposing Robert F. Kennedy Jr. for a position in the Trump cabinet because he fears Kennedy would disrupt the current healthcare system. Many believe Big Pharma is worried about losing its grip on health policies if Kennedy gets into power.
  2. Gottlieb has a long history of connections with pharmaceutical companies, including Pfizer, which raises concerns about conflicts of interest. This background makes people skeptical about his motives and the influence of corporate interests in health decisions.
  3. Kennedy is seen by some as someone who could push for necessary changes in the healthcare system, while Gottlieb represents the status quo that many believe is broken and costly. The debate reflects ongoing frustrations with how healthcare is managed in the U.S.

Pfizer's Delayed Myocarditis Study

Who is Robert Malone • 20 implied HN points • 02 Jul 25
🏥 Health Politics Regulatory Affairs
  1. Pfizer's study on myocarditis in kids is facing challenges with enrollment, making it hard to gather enough participants. This means the study could take longer to finish than expected.
  2. The lengthy five-year follow-up in the study is needed to thoroughly check for any long-term health effects. This is important for understanding the consequences of myocarditis better.
  3. There's no solid evidence that Pfizer is hiding data or being unethical; the delays seem to be due to the difficulty of conducting a rigorous study.

Did FDA know a child had died in Moderna's Covid jab clinical trial? If so, what did the agency do about it?

Unreported Truths • 49 implied HN points • 06 Jan 25
🏥 Health Politics Regulatory Affairs
  1. A child died during Moderna's Covid vaccine trial, and there's confusion about whether the FDA was informed about this death.
  2. The FDA's responses seem deliberately vague, avoiding a clear acknowledgment of the child's death.
  3. Senator Ron Johnson plans to investigate further, which could lead to more transparency from the FDA.

No Foxy Business 🦊

Sector 6 | The Newsletter of AIM • 0 implied HN points • 14 Mar 23
💼 Business Regulatory Affairs
  1. The term 'Foxconned' reflects how people might feel tricked by promises of jobs and progress that don't turn out as expected.
  2. In India, there are changes to labor laws allowing longer hours and shifts, making it easier for companies like Apple to operate there instead of in China.
  3. These changes are part of a larger strategy by the government to attract tech companies, but they raise concerns about workers' rights and job security.